1vag: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1vag" size="450" color="white" frame="true" align="right" spinBox="true" caption="1vag, resolution 2.0Å" /> '''Neuronal nitric oxide...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1vag.gif|left|200px]]<br /><applet load="1vag" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1vag.gif|left|200px]]<br /><applet load="1vag" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1vag, resolution 2.0&Aring;" />
caption="1vag, resolution 2.0&Aring;" />
'''Neuronal nitric oxide synthase oxygenase domain complexed with the inhibitor AR-R17477'''<br />
'''Neuronal nitric oxide synthase oxygenase domain complexed with the inhibitor AR-R17477'''<br />


==Overview==
==Overview==
The high level of amino acid conservation and structural similarity of the, substrate-binding sites of the oxygenase domains of the nitric oxide, synthase (NOS) isoforms (eNOSoxy, iNOSoxy, nNOSoxy) make the, interpretation of the structural basis of inhibitor isoform specificity a, challenge, and provide few clues for the design of new selective, compounds. Crystal structures of iNOSoxy and nNOSoxy complexed with the, neuronal NOS-specific inhibitor AR-R17447 suggest that specificity is, provided by the interaction of the chlorophenyl group with an, isoform-unique substrate access channel residue (L337 in rat neuronal NOS, N115 in mouse inducible NOS). This is confirmed by biochemical analysis of, site-directed mutants. Inhibitors combining guanidinium-like structural, motifs with long chains specifically targeting this residue are good, candidates for rational isoform-specific drug design. Based on this, finding, modifications of AR-R17447 to improve the specificity for the, human isoforms are suggested.
The high level of amino acid conservation and structural similarity of the substrate-binding sites of the oxygenase domains of the nitric oxide synthase (NOS) isoforms (eNOSoxy, iNOSoxy, nNOSoxy) make the interpretation of the structural basis of inhibitor isoform specificity a challenge, and provide few clues for the design of new selective compounds. Crystal structures of iNOSoxy and nNOSoxy complexed with the neuronal NOS-specific inhibitor AR-R17447 suggest that specificity is provided by the interaction of the chlorophenyl group with an isoform-unique substrate access channel residue (L337 in rat neuronal NOS, N115 in mouse inducible NOS). This is confirmed by biochemical analysis of site-directed mutants. Inhibitors combining guanidinium-like structural motifs with long chains specifically targeting this residue are good candidates for rational isoform-specific drug design. Based on this finding, modifications of AR-R17447 to improve the specificity for the human isoforms are suggested.


==About this Structure==
==About this Structure==
1VAG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with ZN, HEM, H4B and ARR as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1VAG OCA].  
1VAG is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=HEM:'>HEM</scene>, <scene name='pdbligand=H4B:'>H4B</scene> and <scene name='pdbligand=ARR:'>ARR</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1VAG OCA].  


==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Fedorov, R.]]
[[Category: Fedorov, R.]]
[[Category: Ghosh, D.K.]]
[[Category: Ghosh, D K.]]
[[Category: Schlichting, I.]]
[[Category: Schlichting, I.]]
[[Category: Vasan, R.]]
[[Category: Vasan, R.]]
Line 24: Line 24:
[[Category: rat nnosoxy complex with ar-r17477]]
[[Category: rat nnosoxy complex with ar-r17477]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 04:33:02 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:33:12 2008''